Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C3b is a crucial protein fragment in the complement system, generated by the proteolytic cleavage of complement component 3 (C3). It acts as an opsonin, tagging pathogens for phagocytosis and amplifying the complement response through convertase formation. C3b plays a key role in bridging innate and adaptive immunity and its deficiency leads to increased susceptibility to infections. Overactivation can contribute to inflammatory diseases.
Covalent surface attachment via exposed thioester bond
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component 3 Fragment b.